» Articles » PMID: 11984562

Polygenic Susceptibility to Breast Cancer and Implications for Prevention

Overview
Journal Nat Genet
Specialty Genetics
Date 2002 May 2
PMID 11984562
Citations 288
Authors
Affiliations
Soon will be listed here.
Abstract

The knowledge of human genetic variation that will come from the human genome sequence makes feasible a polygenic approach to disease prevention, in which it will be possible to identify individuals as susceptible by their genotype profile and to prevent disease by targeting interventions to those at risk. There is doubt, however, regarding the magnitude of these genetic effects and thus the potential to apply them to either individuals or populations. We have therefore examined the potential for prediction of risk based on common genetic variation using data from a population-based series of individuals with breast cancer. The data are compatible with a log-normal distribution of genetic risk in the population that is sufficiently wide to provide useful discrimination of high- and low-risk groups. Assuming all of the susceptibility genes could be identified, the half of the population at highest risk would account for 88% of all affected individuals. By contrast, if currently identified risk factors for breast cancer were used to stratify the population, the half of the population at highest risk would account for only 62% of all cases. These results suggest that the construction and use of genetic-risk profiles may provide significant improvements in the efficacy of population-based programs of intervention for cancers and other diseases.

Citing Articles

Cancer prognosis using base excision repair genes.

Kim J, Kang S, Jo N, Kim S, Jang S Mol Cells. 2025; 48(2):100186.

PMID: 39828060 PMC: 11835649. DOI: 10.1016/j.mocell.2025.100186.


Acceptability of de-intensified screening for women at low risk of breast cancer: a randomised online experimental survey.

Kelley-Jones C, Scott S, Waller J BMC Cancer. 2024; 24(1):1111.

PMID: 39243000 PMC: 11378402. DOI: 10.1186/s12885-024-12847-w.


Metabolites Associated with Polygenic Risk of Breast Cancer.

Samuels E, Parks J, Chu J, McDonald T, Spinelli J, Murphy R Metabolites. 2024; 14(6).

PMID: 38921430 PMC: 11205321. DOI: 10.3390/metabo14060295.


BRCA1 and friends 30 years on.

Foulkes W Nat Rev Genet. 2024; 25(10):671-672.

PMID: 38886216 DOI: 10.1038/s41576-024-00754-6.


The acceptability and clinical impact of using polygenic scores for risk-estimation of common cancers in primary care: a systematic review.

Dannhauser F, Taylor L, Tung J, Usher-Smith J J Community Genet. 2024; 15(3):217-234.

PMID: 38769249 PMC: 11217210. DOI: 10.1007/s12687-024-00709-8.